quality of life in children with juvenile rheumatoid arthritis treated with infliximab

Clicks: 155
ID: 244790
2008
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #31 of 111 articles by views in Biocontrol science

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Juvenile rheumatoid arthritis (JRA) is chronic disease, leading to early incapacitating injury in patients. Treatment of JRA with new expensive biological agents allows obtaining long term remission of disease and improving its prognosis. Estimation of quality of life is one of the main effectiveness criteria of treatment. A quality of life in children who were 2–4 years old treated with infliximab was estimated. 43 patients with different types of JRA were examined. A quality of life was estimated with the help of questionnaire PEDSQL generic core scale, PEDSQL rheumatology module. Index of functional disability was estimated by childhood health assessment questionnaire (CHAQ). Significant increase of quality of life rates and decrease of index of functional disability was registered in 6 weeks of therapy with infliximab. The rates of quality of life in patients with JRA treated with infliximab were significantly equal to that in healthy children in the same age in 6, 12 and 24 months of treatment. Thus, treatment with infliximab significantly increases quality of life in children in 2–4 years old with JRA and their families, decreases negative influence of disease on child's living, improves physical activity and emotional state of patients, and allows improving contact between patients and healthy children in the same age.
Key words: children, juvenile rheumatoid arthritis, quality of life, infliximab.
Reference Key
denisova2008voprosyquality Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;R.V. Denisova;E.I. Alexeeva;V.Yu. Al'bitsky;I.V. Vinyarskaya;S.I. Valieva;T.M. Bzarova;A.M. Alekseeva;V.V. Chernikov
Journal Biocontrol science
Year 2008
DOI
DOI not found
URL
http://vsp.spr-journal.ru:80/jour/article/view/1477
Keywords
Pediatrics

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.